[1]Department of Disease Prevention and Control,Ministry of Health,China Center for Disease Control and Prevention.Epidemiological serosurvey of hepatitis B in the China[M].Beijing:People's Medical Publishing House,2010:55.(in Chinese)卫生部疾病预防控制局,中国疾病预防控制中心.全国人群乙型病毒性肝炎血清流行病学调查报告[M].北京:人民卫生出版社,2010:55.
|
[2]MA L,ALLA NR,LI X,et al.Mother-to-child transmission of HBV:review of current clinical management and prevention strategies[J].Rev Med Virol,2014,24(6):396-406.
|
[3]WANG JS,ZHU QR.Infection of the fetus with hepatitis B e antigen via the placenta[J].Lancet,2000,355(9208):989.
|
[4]ZHANG SL,YUE YF,BAI GQ,et al.Mechanism of intrauterine infection of hepatitis B virus[J].World J Gastroenterol,2004,10(3):437-438.
|
[5] BHAT P,ANDERSON DA.Hepatitis B virus translocates across a trophoblastic barrier[J].J Virol,2007,81(13):7200-7207.
|
[6] WHO.Guidelines for the Prevention,Care and Treatment of Persons with Chronic Hepatitis B Infection[R].Geneva:World Health Organization,2015.
|
[7]HE JY,ZHANG YH,ZHANG YL,et al.Instructional significance of HBV-DNA load in maternal milk on breastfeeding of postpartum women infected with HBV[J].Chin J Prevent Med,2011,45(11):1004-1006.(in Chinese)何佳英,张迎华,张永乐,等.乙型肝炎病毒感染产妇乳汁中乙型肝炎病毒DNA载量对母乳喂养的指导意义[J].中华预防医学杂志,2011,45(11):1004-1006.
|
[8] URGANCI N,AKYILDIZ BN,KALYONCU D,et al.Familial clustering of HBV in families with children who are diagnosed as chronic hepatitis B or inactive carriers of HBV[J].J Child Health Care,2013,17(2):197-203.
|
[9]YIN Y,WU L,ZHANG J,et al.Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus[J].J Infect,2013,66(5):447-452.
|
[10]ZOU H,CHEN Y,DUAN Z,et al.Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBs Ag-positive mothers[J].J Viral Hepat,2012,19(2):e18-e25.
|
[11]HAN L,ZHANG HW,XIE JX,et al.A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus[J].World J Gastroenterol,2011,17(38):4321-4333.
|
[12] YANG J,ZENG XM,MEN YL,et al.Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus---a systematic review[J].Virol J,2008,5:100.
|
[13]CHEN WH,YIN CS,CHANG YK,et al.Neonatal gastric aspirates as a predictor of perinatal hepatitis B virus infections[J].Int JGynaecol Obstet,1998,60(1):15-21.
|
[14]TERRAULT NA,BZOWEJ NH,CHANG KM,et al.AASLD guidelines for treatment of chronic hepatitis B[J].Hepatology,2016,63(1):261-283.
|
[15]HILL JB,SHEFFIELD JS,KIM MJ,et al.Risk of hepatitis Btransmission in breast-fed infants of chronic hepatitis B carriers[J].Obstet Gynecol,2002,99(6):1049-1052.
|
[16]Chinese Society of Hepatology and Chinese Society of infectious Diseases Chinese,Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
[17]SHOUVAL D,ROGGENDORF H,ROGGENDORF M.Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine[J].Med Microbiol Immunol,2015,204(1):57-68.
|
[18]KOMATSU H.Hepatitis B virus:where do we stand and what is the next step for eradication?[J].World J Gastroenterol,2014,20(27):8998-9016.
|
[19] MAST EE,WEINBAUM CM,FIORE AE,et al.A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States:recommendations of the Advisory Committee on Immunization Practices(ACIP)Part II:immunization of adults[J].MMWR Recomm Rep,2006,55(RR-16):1-33,e1-e4.
|
[20] SIBERRY GK,JACOBSON DL,KALKWARF HJ,et al.Lower newborn bone mineral content associated with maternal use of tenofovir disoproxil fumarate during pregnancy[J].Clin Infect Dis,2015,61(6):996-1003.
|
[21] SHAPIRO RL,HOLLAND DT,CAPPARELLI E,et al.Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment[J].J Infect Dis,2005,192(5):720-727.
|
[22] CORBETT AH,KAYIRA D,WHITE NR,et al.Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24weeks post-partum:results of the BAN Study[J].Antivir Ther,2014,19(6):587-595.
|
[23] MIROCHNICK M,TAHA T,KREITCHMANN R,et al.Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life[J].J Acquir Immune Defic Syndr,2014,65(1):33-41.
|
[24] HU Y,CHEN J,WEN J,et al.Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus[J].BMC Pregnancy Childbirth,2013,13:119.
|
[25] KOLAKOWSKA A,GODZIK P,MADALINSKI K.HCV inection in pregnancy[J].Med Dosw Mikrobiol,2014,66(3-4):215-222.
|
[26]PRASAD MR,HONEGGER JR.Hepatitis C virus in pregnancy[J].Am J Perinatol,2013,30(2):149-159.
|
[27] Le CAMPION A,LAROUCHE A,FAUTEUX-DANIEL S,et al.Pathogenesis of hepatitis C during pregnancy and childhood[J].Viruses,2012,4(12):3531-3550.
|
[28] MOK J,PEMBREY L,TOVO P A,et al.When does mother to child transmission of hepatitis C virus occur?[J].Arch Dis Child Fetal Neonatal Ed,2005,90(2):f156-f160.
|
[29]DELAMARE C,CARBONNE B,HEIM N,et al.Detection of hepatitis C virus RNA(HCV RNA)in amniotic fluid:a prospective study[J].J Hepatol,1999,31(3):416-420.
|
[30] Mc DONAGH S,MAIDJI E,MA W,et al.Viral and bacterial pathogens at the maternal-fetal interface[J].J Infect Dis,2004,190(4):826-834.
|
[31]HSIEH TY,YU CH,KUO PL,et al.Acute viral hepatitis C-induced jaundice in pregnancy[J].Taiwan J Obstet Gynecol,2006,45(2):180-182.
|
[32]INDOLFI G,NESI A,RESTI M.Intrafamilial transmission of hepatitis C virus[J].J Med Virol,2013,85(4):608-614.
|
[33] CHECA CC,STOSZEK SK,QUARLERI J,et al.Mother-to-child transmission of hepatitis C virus(HCV)among HIV/HCV-coinfected women[J].J Pediatric Infect Dis Soc,2013,2(2):126-135.
|
[34] OHTO H,TERAZAWA S,SASAKI N,et al.Transmission of hepatitis C virus from mothers to infants.The Vertical Transmission of Hepatitis C Virus Collaborative Study Group[J].N Engl J Med,1994,330(11):744-750.
|
[35]HAYASHIDA A,INABA N,OSHIMA K,et al.Re-evaluation of the true rate of hepatitis C virus mother-to-child transmission and its novel risk factors based on our two prospective studies[J].J Obstet Gynaecol Res,2007,33(4):417-422.
|
[36]PEMBREY L,NEWELL ML,TOVO PA.The management of HCVinfected pregnant women and their children European paediatric HCV network[J].J Hepatol,2005,43(3):515-525.
|
[37] European Peadiatric Hepatitis C Virus Network.A significant sex---but not elective cesarean section---effect on mother-to-child transmission of hepatitis C virus infection[J].J Infect Dis,2005,192(11):1872-1879.
|
[38]FLOREANI A.Hepatitis C and pregnancy[J].World J Gastroenterol,2013,19(40):6714-6720.
|
[39] LIN HH,KAO JH,HSU HY,et al.Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus[J].JInfect Dis,1994,169(3):638-641.
|
[40]YEUNG CY,LEE HC,CHAN WT,et al.Vertical transmission of hepatitis C virus:current knowledge and perspectives[J].World JHepatol,2014,6(9):643-651.
|
[41]AASLD/IDSA HCV Guidance Panel.Hepatitis C guidance:AASLD-IDSA recommendations for testing,managing,and treating adults infected with hepatitis C virus[J].Hepatology,2015,62(3):932-954.
|
[42]TOSONE G,MARAOLO AE,MASCOLO S,et al.Vertical hepatitis C virus transmission:main questions and answers[J].World JHepatol,2014,6(8):538-548.
|
[43]SHEPARD CW,FINELLI L,ALTER MJ.Global epidemiology of hepatitis C virus infection[J].Lancet Infect Dis,2005,5(9):558-567.
|
[44]REZVANI M,KOREN G.Pregnancy outcome after exposure to injectable ribavirin during embryogenesis[J].Reprod Toxicol,2006,21(1):113-115.
|